Business Segments Island Pharmaceuticals Limited
Equities
ILA
AU0000138869
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4900 AUD | +1.03% |
|
+15.29% | +13.95% |
| 09/03 | Island Pharmaceuticals Begins Strategic Collaboration With Australian Infectious Disease Research Organization | MT |
| 04/03 | Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold | FI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||
Pharmaceuticals | - | - | 11.06K | 1.27M | 119K | |
Total Assets | 6.64M | 4.9M | 2.05M | 2.56M | 7.49M | |
Interest Expense | - | - | -9K | -46.2K | -27.31K | |
EBT | -2.13M | -2.61M | -2.83M | -2.86M | -3.92M | |
Net Income | -2.13M | -2.61M | -2.83M | -2.86M | -3.92M |
Geographical Revenue Distribution History
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Total Assets | 6.64M | 4.9M | - | - | - | |
Net Income | -2.13M | -2.61M | - | - | - | |
EBT | -2.13M | -2.61M | - | - | - |
- Stock Market
- Equities
- ILA Stock
- Financials Island Pharmaceuticals Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition